For example, the proportion of PD1+TIM3+ double-positive CD4+ T cells could predict poor survival in adult B-ALL patients [10, 11], and increased frequencies of activated cytokine-producing natural killer (NK) cells could independently predict poor clinical outcome in ALL patient [12]. The gene discussed is HAVCR2; the disease is precursor B-cell acute lymphoblastic leukemia.